Samfara has completed the acquisition of Chr. Olesen Synthesis from Chr. Olesen and funds managed by Signet Healthcare Partners, marking the European life sciences investment firm's first investment.
Dublin, April 01, 2025 (GLOBE NEWSWIRE) -- The "Peptide Synthesis Market Industry Trends and Global Forecasts to 2035, by Type of Peptide Synthesis Method, Type of Chemical Synthesis, Contract ...
New York, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global API Intermediate Market Size, Share & Industry Trends Analysis Report By Type, By End User, By ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results